References
- Amoras AL, da Silva MT, Zollner RL, et al. (2007). Expression of Fc gamma and complement receptors in monocytes of X-linked a gamma globulinaemia and common variable immunodeficiency patients. Clin Exp Immunol, 150, 422–8. PMID: 17900300
- Ando M, Tu W, Nishijima K, Iijima S. (2008). Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs. Biochem Biophys Res Commun, 369, 878–83. PMID: 18325328
- Barnes PJ, Shapiro SD, Pauwels RA. (2003). Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J, 22, 672–88. PMID: 14582923
- Boyd CR, Orr SJ, Spence S, et al. (2009). Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production. J Immunol, 183, 7703–9. PMID: 19933851
- Cao H, Crocker PR. (2011). Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? Immunology, 132, 18–26. PMID: 21070233
- Chandy D, Aronow WS. (2006). Management of acute exacerbations in chronic obstructive pulmonary disease. Compr Ther, 32, 230–5. PMID: 17898428
- China Medical Association of Respiratory Disease Society. (2002). The guideline for diagnosis and management of COPD formulated by the group of COPD from China medical association of respiratory disease society. Chin J Tuberculosis Respir Dis, 25, 453
- Crocker PR. (2002). Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr Opin Struct Biol, 12, 609–15. PMID: 12464312
- Crocker PR, Varki A. (2001a). Siglecs in the immune system. Immunology, 103, 137–45. PMID: 11412300
- Crocker PR, Varki A, et al. (2001b). Siglecs sialic acids and innate immunity. Trends Immunol, 22, 337–42. PMID: 11377294
- Danikas DD, Karakantza M, Theodorou GL, et al. (2008). Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol, 154, 87–97. PMID: 18727624
- Davril M, Degroote S, Humbert P, et al. (1999). The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection. Glycobiology, 9, 311–21. PMID: 10024669
- Fossati G, Bucknall RC, Edwards SW. (2001). Fcgamma receptors in autoimmune diseases. Eur J Clin Invest, 31, 821–31. PMID: 11589725
- Freeman SD, Kelm S, Barber EK, et al. (1995). Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood, 85, 2005–12. PMID: 7718872
- Hacievliyagil SS, Gunen H, Mutlu LC, et al. (2006). Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med, 100, 846–54. PMID: 16214322
- Hanriot D, Bello G, Ropars A, et al. (2008). C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes. Thromb Haemost, 99, 558–69. PMID: 18327405
- Hoffmann JJ. (2009). Neutrophil CD64: a diagnostic marker for infection and sepsis. Clin Chem Lab Med, 47, 903–16. PMID: 19642859
- Knochel JP. (1993). Mechanisms of rhabdomyolysis. Curr Opin Rheumatol, 5, 725–31. PMID: 8117534
- Lajaunias F, Dayer JM, Chizzolini C. (2005). Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling. Eur J Immunol, 35, 243–51. PMID: 15597323
- Lazovic B. (2012). Correlation of CRP and serum level of fibrinogen with severity of disease in chronic obstructive pulmonary disease patients. Med Arh, 66, 159–60. PMID: 22822613
- Lock K, Zhang J, Lu J, et al. (2004). Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells. Immunobiology, 209, 199–207. PMID: 15481154
- Montecucco F, Steffens S, Burger F, et al. (2008). C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes. J Leukoc Biol, 84, 1109–19. PMID: 18591415
- Nguyen DH, Hurtado-Ziola N, Gagneux P, et al. (2006). Loss of Siglec expression on T lymphocytes during human evolution. Proc Natl Acad Sci USA, 103, 7765–70. PMID: 16682635
- Noguera A, Batle S, Miralles C, et al. (2001). Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax, 56, 432–7. PMID: 11359957
- Okayama Y, Kirshenbaum AS, Metcalfe DD. (2000). Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: Up-regulation by IFN-gamma. J Immunol, 164, 4332–9. PMID: 10754333
- Paul SP, Taylor LS, Stansbury EK, et al. (2000). Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood, 96, 483–90. PMID: 10887109
- Peiper SC, Ashmun RA, Look AT. (1988). Molecular cloning, expression, and chromosomal localization of a human gene encoding the CD33 myeloid differentiation antigen. Blood, 72, 314–21. PMID: 3390608
- Pierelli L, Teofili L, Menichella G, et al. (1993). Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells. Br J Haematol, 84, 24–30. PMID: 7687858
- Plesa C, Chelghoum Y, Plesa A, et al. (2008). Prognostic Value of Immunophenotyping in Elderly Patients with Acute Myeloid Leukemia: A single-institution experience. Cancer, 112, 572–80. PMID: 18085638
- Ronchi MC, Piragino C, Rosi E, et al. (1996). Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax, 51, 1000–4. PMID: 8977600
- Scapini P, Carletto A, Nardelli B, et al. (2005). Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications forinflammatory diseases. Blood, 105, 830–37. PMID: 15358625
- Sethi S, Wrona C, Eschberger K. (2008). Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 177, 491–7. PMID: 18079493
- Shapiro SD, Ingenito EP. (2005). The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am J Respir Cell Mol Biol, 32, 367–72. PMID: 15837726
- Snider GL. (2003). Nosology for our day: its application to chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 167, 678–83. PMID: 12598211
- Solanes I, Bolíbar I, Llauger MA, et al. (2012). Characteristics of stable chronic obstructive pulmonary disease related to systemic inflammation. Med Clin (Barc), 139, 430--436. PMID: 22766062
- Soler L, Martínez-Subiela S, Tecles F, et al. (2008). Serum total sialic acid in pigs: new possibilities for an old inflammatory biomarker. J Vet Diagn Invest, 20, 799–803. PMID: 18987233
- Sonnenburg JL, Altheide TK, Varki A. (2004). A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor. Glycobiology, 14, 339–46. PMID: 14693915
- Tseke P, Grapsa E, Stamatelopoulos K, et al. (2008). Correlations of sialic acid with markers of inflammation, atherosclerosis and cardiovascular events in hemodialysis patients. Blood Purif, 26, 261–6. PMID: 18401156
- Ulyanova T, Shah DD, Thomas ML. (2001). Molecular cloning of MIS, a myeloid inhibitory siglec, that binds protein-tyrosine phosphatases SHP-1 and SHP-2. J Biol Chem, 276, 14451–8. PMID: 11278955